175 related articles for article (PubMed ID: 3420246)
1. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
[TBL] [Abstract][Full Text] [Related]
3. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
[TBL] [Abstract][Full Text] [Related]
4. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
[TBL] [Abstract][Full Text] [Related]
5. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
Sze G; Bravo S; Krol G
Radiology; 1989 Mar; 170(3 Pt 1):849-56. PubMed ID: 2916042
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
[TBL] [Abstract][Full Text] [Related]
7. Gadopentetate dimeglumine: observations on the clinical research process.
Kieffer SA
Radiology; 1990 Jan; 174(1):7-8. PubMed ID: 2403685
[No Abstract] [Full Text] [Related]
8. Experimental radiation injury: combined MR imaging and spectroscopy.
Grossman RI; Hecht-Leavitt CM; Evans SM; Lenkinski RE; Holland GA; Van Winkle TJ; McGrath JT; Curran WJ; Shetty A; Joseph PM
Radiology; 1988 Nov; 169(2):305-9. PubMed ID: 3174977
[TBL] [Abstract][Full Text] [Related]
9. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
Jensen MC; Brant-Zawadzki M
AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
[TBL] [Abstract][Full Text] [Related]
11. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
Calabresi PA; Tranquill LR; Dambrosia JM; Stone LA; Maloni H; Bash CN; Frank JA; McFarland HF
Ann Neurol; 1997 May; 41(5):669-74. PubMed ID: 9153530
[TBL] [Abstract][Full Text] [Related]
12. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.
Mihara F; Gupta KL; Joslyn JN
Radiat Med; 1994; 12(4):147-51. PubMed ID: 7809407
[TBL] [Abstract][Full Text] [Related]
14. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
16. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
18. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
Geirnaerdt MJ; Bloem JL; Eulderink F; Hogendoorn PC; Taminiau AH
Radiology; 1993 Mar; 186(3):813-7. PubMed ID: 8430192
[TBL] [Abstract][Full Text] [Related]
19. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas.
Hamed MM; Hamm B; Ibrahim ME; Taupitz M; Mahfouz AE
AJR Am J Roentgenol; 1992 Feb; 158(2):303-7. PubMed ID: 1729787
[TBL] [Abstract][Full Text] [Related]
20. Routine use of gadopentetate dimeglumine in cranial MR imaging of patients with AIDS.
Elster AD
AJR Am J Roentgenol; 1993 Sep; 161(3):680-1. PubMed ID: 8352135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
